PT  - JOURNAL ARTICLE
AU  - Ahangari, Samira
AU  - Chavis, Celeste
AU  - Jeihani, Mansoureh
TI  - PUBLIC TRANSIT RIDERSHIP ANALYSIS DURING THE COVID-19 PANDEMIC
AID  - 10.1101/2020.10.25.20219105
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.25.20219105
4099  - http://medrxiv.org/content/early/2020/10/27/2020.10.25.20219105.short
4100  - http://medrxiv.org/content/early/2020/10/27/2020.10.25.20219105.full
AB  - This study investigates the effect of the coronavirus (COVID-19) pandemic on public transport ridership in Baltimore and nine other U.S. cities similar to Baltimore, in terms of population and service area, during the first five months of 2020. The analysis is based on ridership numbers, vehicle revenue hours, and vehicles operated in maximum service. A compliance analysis was done between 2020 and 2019, as well as a monthly analysis of 2020 by mode and type of services. In comparison to 2019, the ridership decreases from March, the start of the pandemic, while all ten cities experienced the most decrease in ridership in April.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Urban Mobility & Equity Center at Morgan State University and the University Transportation Center(s) Program of the U.S. Department of Transportation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:RE: IRB #20/06-0080All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://docs.google.com/forms/d/1qOY4LCLEWmpMtPZYDlE5UmmRqCmUuhIi7-R97EAcPF4/edit#responseshttps://docs.google.com/forms/d/1qOY4LCLEWmpMtPZYDlE5UmmRqCmUuhIi7-R97EAcPF4/edit#responses